Innovation in pharma not a prescription for boosting logistics profits

AI Summary

Pharma.Aero secretary general Frank van Gelder cautioned freight forwarders against assuming that demand for complex, high-value pharmaceutical therapies will translate into higher shipment volumes or stronger logistics profits. The article highlights uncertainty about the commercial benefits of growth in specialized pharmaceutical products.

Forwarders should beware of confusing demand for complex, high-value pharmaceutical therapies with expectations of increased volumes or improved profitability, warned Pharma.Aero secretary general Frank van Gelder this week. The post Innovation in pharma not a prescription for boosting logistics profits appeared first on The Loadstar.